AU7322096A - Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dih ydro-7h-pyrido{3,2,1,ij}-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial - Google Patents

Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dih ydro-7h-pyrido{3,2,1,ij}-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial

Info

Publication number
AU7322096A
AU7322096A AU73220/96A AU7322096A AU7322096A AU 7322096 A AU7322096 A AU 7322096A AU 73220/96 A AU73220/96 A AU 73220/96A AU 7322096 A AU7322096 A AU 7322096A AU 7322096 A AU7322096 A AU 7322096A
Authority
AU
Australia
Prior art keywords
methyl
benzoaxadiazine
pyrido
piperazinyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73220/96A
Inventor
Roderick John Dorgan
Richard Andrew Bentley Webster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU7322096A publication Critical patent/AU7322096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
AU73220/96A 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dih ydro-7h-pyrido{3,2,1,ij}-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial Abandoned AU7322096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9600888.3A GB9600888D0 (en) 1996-01-17 1996-01-17 Method of treatment
GB9600888 1996-01-17
PCT/GB1996/002673 WO1997025991A1 (en) 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial

Publications (1)

Publication Number Publication Date
AU7322096A true AU7322096A (en) 1997-08-11

Family

ID=10787124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73220/96A Abandoned AU7322096A (en) 1996-01-17 1996-10-31 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dih ydro-7h-pyrido{3,2,1,ij}-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial

Country Status (5)

Country Link
EP (1) EP0874633A1 (en)
JP (1) JP2000501108A (en)
AU (1) AU7322096A (en)
GB (1) GB9600888D0 (en)
WO (1) WO1997025991A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259804B1 (en) * 1986-09-12 1993-11-18 F. Hoffmann-La Roche Ag Pyrido[3,2,1-ij]-1,3,4-benzoxadiazine derivatives, process for their preparation, resulting pharmaceutical preparations and intermediates for use in the process

Also Published As

Publication number Publication date
GB9600888D0 (en) 1996-03-20
WO1997025991A1 (en) 1997-07-24
EP0874633A1 (en) 1998-11-04
JP2000501108A (en) 2000-02-02

Similar Documents

Publication Publication Date Title
AU5522798A (en) Water-responsive polymer compositions and method of making the same
AU4520697A (en) Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation
AU1315797A (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
GR3036015T3 (en) Substituted oxazolidinone and their use as antibacterial medicine
AU682107B2 (en) Disengageable descender with self-locking of the rope
EP0815838A3 (en) External skin treatment composition
AU5860396A (en) Substituted oxazoles for the treatment of inflammation
AU1979997A (en) Skin toning formulation
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
AU9083098A (en) Diagnosis of ocular pathogens
AU2952997A (en) Thiocyano-triazolyl derivatives and their use as microbicides
AU3590897A (en) Traveler's quarters
AU2896597A (en) Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
AU6525296A (en) Wound treatment composition
AU5315898A (en) Compositions for disinfection of skin and mucous membrane
AU4777097A (en) Novel piperidineketocarboxylic acid derivatives, their preparation and use
AU4047697A (en) Use of microorganisms for processing bioprosthetic tissue
AU7478694A (en) 3-aryl or heteroaryl-7-heteroaralkylamido cephalosporin compounds, compositions and methods of use
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU3569293A (en) 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals
AU7322096A (en) Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dih ydro-7h-pyrido{3,2,1,ij}-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted